Co-Diagnostics
CODX
37 hedge funds and large institutions have $4.29M invested in Co-Diagnostics in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
3% more funds holding
Funds holding: 36 → 37 (+1)
0.14% more ownership
Funds ownership: 0.46% → 0.6% (+0.14%)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
22% less capital invested
Capital invested by funds: $5.52M → $4.29M (-$1.23M)
68% less call options, than puts
Call options by funds: $97K | Put options by funds: $299K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisory Group
Redmond,
Washington
|
+$1.24M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$75.4K |
| 3 |
Squarepoint
New York
|
+$29.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$25.5K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$17.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$19.1K |
| 2 |
VF
Virtu Financial
New York
|
-$14K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$13.2K |
| 4 |
Renaissance Technologies
New York
|
-$12.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$11.7K |
CODX Hedge Fund Activity: Q4 2024 in Review
37 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q4 2024, worth a combined $4.29M — down 22% from $5.52M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CODX positions and 5 closed out — a net gain of 2 holders — while 8 added to existing stakes and 9 trimmed.
The largest buyer was Private Advisory Group, opening a new position worth an estimated $1.24M. The largest seller was Jane Street, cutting an estimated $19.1K.
- 37 institutional investors held Co-Diagnostics (CODX) as of Q4 2024, up from 36 in Q3 2024.
- Funds reported $4.29M of Co-Diagnostics stock for Q4 2024, down 22% quarter-over-quarter.
- 7 funds opened new Co-Diagnostics positions in Q4 2024 and 5 closed out, a net change of +2 holders.
- The largest Co-Diagnostics buyer in Q4 2024 was Private Advisory Group, an estimated $1.24M added.
- The largest Co-Diagnostics seller in Q4 2024 was Jane Street, an estimated $19.1K sold.
Based on aggregated 13F filings for Q4 2024.